skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Good Afternoon 5i,

Your thoughts on Brookfield real estate (BRE)?

Thanks
Read Answer Asked by Paul on April 01, 2014
Q: Do you have any news on ICP? I am trying to clean up my portfolio and have taken quite a loss on a few stocks, this being one of them. Any advise? Thank-you!
Read Answer Asked by Denis on April 01, 2014
Q: Hello Peter & Co.
I came across yesterday with 2 names that aroused my interest.
One of them is Knight Therapeutics (GUD-V); same team as Paladin Labs and our Pharma sector in Canada is very limited.
The other is Kelso Technologies (KLS-V) which produces among other things pressure release valves; a very topical subject related to railcar safety.
Could you please comment on them?
Thanks,
Tony
Read Answer Asked by Antoine on April 01, 2014
Q: What is your overall assessment on dap.u xpel technologies earnings realease.
Read Answer Asked by samuel on April 01, 2014
Q: I have seen the discussion on Molycorp mcp, which goes back to Jan 2013 and did not encourage purchasing. How is it now, but, more generally, is there anything in rare earths that should be considered?
Read Answer Asked by Gregory on April 01, 2014
Q: Dear Peter and Team: What do you think of Kelso's (KLS) results and prospects?
Read Answer Asked by Roland on April 01, 2014
Q: Just wondering if you have any thoughts on ICP? I have held it for some time now and have taken a loss. I am considering selling it. Thank-you!
Read Answer Asked by Denis on April 01, 2014
Q: Dear Team:' I would like your opinion about intellipharmaceuticals please. The ticker is I on the TSX. It currently trades at $4.72. Jean
Read Answer Asked by jean on April 01, 2014
Q: What is your view on US GEOTHERMALS earning and the outlook for the future.
Tom
Read Answer Asked by Tom on April 01, 2014
Q: E - Can you comment on their latest earnings and how it compares to market expectations. Thanks.
Read Answer Asked by wendy on April 01, 2014
Q: Would much appreciate your analysis of Aeterna Zentaris(aez).Thanks for your insight.
Read Answer Asked by Maurice on March 31, 2014
Q: Good morning,

Agjunction (AJX) recently reported earnings. May I please have your comments on it and is it an opportunity to enter this stock.

Thanks for your great service.

Doug
Read Answer Asked by Doug on March 31, 2014
Q: Hello Dynacor (DNG) just reported today and the numbers look quite good to me. I would appreciate your take on this company and their 2013 results
As always very much appreciate your service
Read Answer Asked by Robert on March 31, 2014
Q: Hi Peter, a very illiquid stock, Senvest (SEC.to) is showing huge earnings, trades at only 2x or so right now. Any thoughts on this co, is it just too illiquid to touch or is it worth a taste.

Thanks a lot
Read Answer Asked by Christopher on March 31, 2014
Q: I would like your view on WESTERONE INC. The company seems to have the business , but not performing well in all areas ,the stock price is declining daily.
Are there other forces driving the price down like the recent debenture redemption for example?
Insider trading seems neutral I believe, Institutional sell off perhaps?
I saw your brief message in Stock Chase could you expand on this?
Is it time to bail or hold on? I bought at $8.15
Austin Jeffries
Read Answer Asked by Austin on March 31, 2014
Q: re VXS

Have been watching VIXS Systems for the past 3 months since it was recommended on Market Call and was awarded the LG contract for their smart TV for which VXS has the best chip set for the next generation technology.

Since then, it has seen a steady decline (just under 45% since Jan 23) and as of today has seen it's first upswing in some time.

Can you give us any updates on the company that you see relevant at this time?

Thank You Peter & Company
Read Answer Asked by Gord on March 28, 2014
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!